These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26098302)

  • 21. Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis.
    West NP; Thomson SA; Triccas JA; Medveczky CJ; Ramshaw IA; Britton WJ
    Vaccine; 2011 Oct; 29(44):7759-65. PubMed ID: 21846485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
    Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
    Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
    Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
    Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
    Deng YH; He HY; Zhang FJ
    Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis.
    Counoupas C; Pinto R; Nagalingam G; Britton WJ; Triccas JA
    Vaccine; 2018 May; 36(19):2619-2629. PubMed ID: 29627232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine.
    Li H; Li R; Zhong S; Ren H; Zou Y; Chen X; Shi X; Wang M; Long H; Luo Y
    Vaccine; 2006 Feb; 24(9):1315-23. PubMed ID: 16219397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT6 fusion protein against persistent tuberculosis infection in mice.
    Wang P; Wang L; Zhang W; Bai Y; Kang J; Hao Y; Luo T; Shi C; Xu Z
    Hum Vaccin Immunother; 2014; 10(1):150-8. PubMed ID: 23982126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice.
    Chen Z; Gupta T; Xu P; Phan S; Pickar A; Yau W; Karls RK; Quinn FD; Sakamoto K; He B
    Vaccine; 2015 Dec; 33(51):7217-7224. PubMed ID: 26552000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation of TAT-Ag85B protein vaccine and evaluation of its anti-Myobacterium tuberculosis effect].
    Zhang R; Wang W; Hu D; Wang W; Xing Y; He J; Dai J; Wu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):49-53. PubMed ID: 25575059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attempted immunotherapy for Mycobacterium tuberculosis with viral and protein vaccines based on Ag85B-ESAT6 in a mouse model.
    You Q; Jiang C; Kong W; Wu Y
    Acta Microbiol Immunol Hung; 2012 Mar; 59(1):63-75. PubMed ID: 22510288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.
    Zhu Bd; Qie Yq; Wang Jl; Zhang Y; Wang Qz; Xu Y; Wang Hh
    Eur J Pharm Biopharm; 2007 Jun; 66(3):318-26. PubMed ID: 17280823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
    Deng Y; Bao L; Yang X
    Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.
    Ballester M; Nembrini C; Dhar N; de Titta A; de Piano C; Pasquier M; Simeoni E; van der Vlies AJ; McKinney JD; Hubbell JA; Swartz MA
    Vaccine; 2011 Sep; 29(40):6959-66. PubMed ID: 21787826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
    Lu Y; Xu Y; Yang E; Wang C; Wang H; Shen H
    Scand J Immunol; 2012 Sep; 76(3):271-7. PubMed ID: 22671973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein.
    Shi C; Chen L; Chen Z; Zhang Y; Zhou Z; Lu J; Fu R; Wang C; Fang Z; Fan X
    Vaccine; 2010 Jul; 28(32):5237-44. PubMed ID: 20538090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.
    Olsen AW; Williams A; Okkels LM; Hatch G; Andersen P
    Infect Immun; 2004 Oct; 72(10):6148-50. PubMed ID: 15385521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H1:IC31 vaccination is safe and induces long-lived TNF-α
    Mearns H; Geldenhuys HD; Kagina BM; Musvosvi M; Little F; Ratangee F; Mahomed H; Hanekom WA; Hoff ST; Ruhwald M; Kromann I; Bang P; Hatherill M; Andersen P; Scriba TJ;
    Vaccine; 2017 Jan; 35(1):132-141. PubMed ID: 27866772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model.
    Sibley L; Reljic R; Radford DS; Huang JM; Hong HA; Cranenburgh RM; Cutting SM
    FEMS Microbiol Lett; 2014 Sep; 358(2):170-9. PubMed ID: 24990572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and therapeutic effects of recombinant Ag85AB fusion protein vaccines in mice infected with Mycobacterium tuberculosis.
    Liang Y; Zhang J; Yang Y; Bai X; Yu Q; Li N; Hou Y; Shi Y; Wang L; Wu X
    Vaccine; 2017 Jul; 35(32):3995-4001. PubMed ID: 28625522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.